3648 results for «2498»
3648 results
Leading dose solutions for your interventions
18 May 2021 – From EuroPCR 2021
Watch this session presented by Laurent Fieldman in order to understand how innovations can help you optimising dose in your procedures, to learn about latest dose reduction tools for complex interventions, and to review expert perspective on using innovative dose reduction tools.
The future of PCI seems bright - The MagicTouch sirolimus-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...
RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Atul Pathak in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...
The PASCAL platform: successfully and confidently treating MR
18 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas van Mieghem, Fabien Praz and Peter Lüdike in order to learn about the PASCAL platform and its differentiated features, to discuss how to identify patients for the treatment with the PASCAL platform, and to review clinical data and discuss patient outcomes...
EBC MAIN - the European Bifurcation Club left main coronary bifurcation study
19 May 2021 – From EuroPCR 2021
In this session, originally presented during EuroPCR 2021, discover the EBC Main study and follow the in-depth discussion lead with the PCR clinical research team about the results of this important trial comparing stepwise provisional versus systematic dual stenting strategies.
EuroIntervention - Most cited papers of the year 2020
18 May 2021 – From EuroPCR 2021
Thanks to this session, which was originally presented during EuroPCR 2021, by D. Capodanno, Editor-in-chief, and N. Gonzalo & D. Mylotte, deputy editors, discover the top 3 most cited EuroIntervention Journal papers in 2020, and hear the reaction of the winner, interviewed for the occasion.
EuroPCR 2021 Hotlines / Late-Breaking Trials: CENTURY JSV, SORT OUT IX, OUTDES, Epic02-RANGO, PIONEER III, and more!
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in stents:
- First machine learning derived risk score for target lesion failure
- Ultrathin versus Conventional Second-Generation DES: Meta-Analysis of RCTs
- Five-year outcomes after coronary stenting of small vessels - CENTURY JSV study
- 2-year outcomes of the randomized SORT OUT IX Trial
- Outcomes of...
A randomised study comparing imaging guided implantation of Orsiro and Xience - CASTLE study
20 May 2021 – From EuroPCR 2021
Watch this LBT session, which was originally presented during EuroPCR 2021, to find out more about the CASTLE study, whose aim is to access the results of two types of DES implanted with image guidance in all-comers.
Best of the European Heart Journal
19 May 2021 – From EuroPCR 2021
Watch this session, originally presented during EuroPCR 2021 by F. Crea, Editor-in-chief, and C. Berry, Executive Editor, to find out more, both about the most cited European Heart Journal original research article, and the most Almetric scored one, and enjoy in-depth analysis of the SOLVE-TAVI and DAEDALUS studies in...
Empowering DES performance in complex patients to maximise efficacy and safety outcomes
20 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in BRS/BVS:
- Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
- France Absorb registry: final five years follow-up
- A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
- Three-year follow-up of the prospective bvs stemi strategy-it study
- Final five-year results of AIDA trial
- Bioresorbable...
Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme
20 May 2021 – From EuroPCR 2021
Watch this session presented by Simon Kennon, Olivier Darremont, Helene Eltchaninoff, Derk Frank, Sandra Lauck and Francesco Saia in order to improve access to high quality of care with safe early discharge for selected patients in Europe, to identify strategies to reduce hospital stay and optimise TAVI programmes for...
The new Evolut PRO+ system: optimal procedural outcomes in all patients
20 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in drugs & devices:
- POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
- CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
- PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
Improving personalised vascular care using novel technologies: how can I start?
19 May 2021 – From EuroPCR 2021
Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.
EuroPCR 2021 Hotlines / Late-Breaking Trials: CLASP, CHOICE-MI, CHOICE-MI MAC, TENDER, and Global EXPAND
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in mitral valve replacement & repair:
- 2-year outcomes for transcatheter mitral repair from the CLASP study
- The choice of optimal transcatheter treatment for mitral insufficiency registry
- Outcomes of patients treated for mitral annulus calcification
- TENDER - TENDyne European expeRience registry: Early outcome
- Safety...
EAPCI-PCR Fellows Course 2021 - Coronary track: Ambiguous LM/PCI strategy for mid-LAD bifurcation
14 Apr 2021 – From EuroPCR 2021
The best PCI strategies for an ambiguous LM, then a mid-LAD bifurcation. With golden tips from G. Stankovic and T. Lefèvre!
The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at...
EAPCI-PCR Fellows Course 2021 - Coronary track: Interventions for calcified coronary lesions
14 Apr 2021 – From EuroPCR 2021
The role of imaging for procedural planning and the best indications for specific plaque modification techniques!
The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at the beginning of their careers....
PCR's Got Talent Winning Submission: POT Puff Study
18 May 2021 – From EuroPCR 2021
Consult this session to discover the winning abstract submitted during the second round of EuroPCR 2021 PCR's Got Talent, a unique abstract competition for young practitioners, and get a concentrate of the POT Puff study!
LM trifurcation STEMI
18 May 2021 – From EuroPCR 2021
Watch the case of this 69-year-old male patient suffering from LM trifurcation with sub-occlusive lesion who presented with severe bradycardia and hypotension after angios: would you have treated him the same way?
